| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
National Jewish Medical and Research Center, Denver, Colorado 80206 [F. Z., L. N., K. T., E. W. G., L. Z., R. J. M.]; Denver Health and Hospitals, Denver, Colorado 80204 [J. H. F.]; University of Colorado Health Sciences Center, Denver, Colorado 80262 [A. M. Ma., A. M. Me., L. D. D-N.]; Memorial Sloan Kettering Cancer Center, New York, New York 20021 [W. P.]; and National Cancer Institute, Rockville, Maryland 20850 [S. M. U., S. B. J.]
Most murine lung tumors are composed of differentiated epithelial cells. We have reported previously that surfactant protein (SP)-D is expressed in urethane-induced tumors. Serum levels of SP-D are increased in patients with interstitial lung disease and acute respiratory distress syndrome and in rats with acute lung injury but have not been measured in mice. In this study, we sought to determine whether SP-D could be detected in murine serum and discovered that it was increased in mice bearing lung tumors. Serum SP-D concentration was 5.0 ± 0.2 ng/ml in normal C57BL/6 mice, essentially absent in SP-D nulls, and 63.6 ± 9.0 ng/ml in SP-D-overexpressing mice. SP-D in serum was verified by immunoblotting. Serum SP-D was increased in mice bearing tumors induced by three different protocols, and the SP-D level correlated with tumor volume. However, in mice with a single adenoma or a few adenomas, SP-D levels were usually within the normal range. SP-D was expressed by the tumor cells, and there was also a field effect whereby type II cells near the tumor expressed more SP-D than type II cells in the remainder of the lung. Serum SP-D was also increased by lung inflammation. In airway inflammation induced by aerosolized ovalbumin in sensitized BALB/c mice, the serum levels were elevated after challenge. In conclusion, serum SP-D concentration is increased in mice bearing lung tumors and generally reflects the tumor burden but is also elevated during lung inflammation.
This article has been cited by other articles:
![]() |
D. D. Sin, S. F. P. Man, A. McWilliams, and S. Lam Surfactant Protein D and Bronchial Dysplasia in Smokers at High Risk of Lung Cancer Chest, September 1, 2008; 134(3): 582 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Sin, P. S. Pahlavan, and S.F. P. Man Review: Surfactant protein D: A lung specific biomarker in COPD? Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 65 - 74. [Abstract] [PDF] |
||||
![]() |
F. Kassie, L. B. Anderson, R. Scherber, N. Yu, D. Lahti, P. Upadhyaya, and S. S. Hecht Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein Levels Cancer Res., July 1, 2007; 67(13): 6502 - 6511. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, D. Bellgrau, L. D. Dwyer-Nield, A. M. Malkinson, R. C. Duke, T. C. Rodell, and A. Franzusoff Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy Cancer Res., August 1, 2004; 64(15): 5084 - 5088. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Malkinson Evidence That Inflammation Encourages Pulmonary Adenocarcinoma Formation in Mice: Clinical Implications Chest, May 1, 2004; 125(5_suppl): 154S - 155S. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |